ARCHIVES

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

NC-Approved Clinical Trials

June 27, 2003

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994